He was subsequently found to have an left upper lobe aspergilloma which was initially treated with amphotericin, which led to the patient having seizures.
He was then placed in a phenobarbital coma, which slowly resolved and was started on itraconazole therapy.
The patient was started on Meclizine and initially showed improvement on that.
Additionally, multiple medications that the patient was taking have been associated with dizziness, including the patient's seizure medications.
Infectious disease:  The issue of reverse transcript ACE inhibitors was revisited within the last two weeks.
When the amylase level returns to normal, the infectious disease service will revisit the issue of reverse transcript ACE inhibitors.
The patient was started on protease inhibitors on [**2123-12-26**].
According to fetal distress, the patient may stay on double protease inhibitor therapy for up to three months before resistance occurs.
The plan is to revisit the issue of reverse transcript ACE inhibitors once the patient's amylase level is within normal limits.
The patient was started on acyclovir.
DISCHARGE MEDICATIONS: Acyclovir 800 mg p.o.t.i.d.
Amprenavir 450 mg p.o.b.i.d.
Azithromycin 1.2 gm p.o.q.
Desitin applied to affect area p.r.n.
Colace 100 mg p.o.b.i.d.
Ibuprofen 600 mg p.o.t.i.d.
Itraconazole 200 mg p.o.q.d.
Lansoprazole 30 mg p.o.q.d.
Levetiracetam 500 mg p.o.b.i.d.
Meclizine 25 mg p.o.b.i.d.
Metoclopramide 5 mg p.o.q.i.d.
Multivitamins one p.o.q.d.
Neutra-Phos one p.o.q.d.
Phenobarbital 90 mg p.o.b.i.d.
Ritonavir 100 mg p.o.b.i.d.
Bactrim DS one p.o.q.d.
Tobramycin one drop applied to each eye q.i.d.
